10.199% filed a letter requesting the company to hold extraordinary shareholders? meeting to consider the matters of (1) rights offering of newly issued shares and share warrants and (2) change of the

SUMMARY EXECUTIVE SUMMARY 2 2017 2018 % change Q3’2018 Q4’2018 % change million Baht million Baht y-on-y million Baht million Baht q-on-q Sales and service income 31,482 36,585 16.2% 9,691 9,933 2.5% EBITDA

find full detail on www.trisrating.com) As regards to BGRIM’s annual general meeting (AGM) held on 26 April 2018, BGRIM also granted shareholder approval on issuance of bond in the amount up to Baht

63.1% of NNP. ABBREVIATION & OUR PROJECTSFINANCIAL PERFORMANCE FINANCIAL POSITION PROGRESS OF PROJECTS UNDER CONSTRUCTION EXECUTIVE SUMMARY EXECUTIVE SUMMARY 2 6M’2017 6M’2018 % change Q1’2018 Q2’2018

11 Tambon Ladsawai, Amphoe Lamlukka, Pathumthani 12150 Paid up capital 7,000,000 baht Remarks: During the development of UU’s project, UU will increase the capital to 117 million baht, to be invested

EXECUTIVE SUMMARY EXECUTIVE SUMMARY 2 9M’18 9M’19 change Q3’18 Q2’19 Q3’19 change change Btmn Btmn y-on-y Btmn Btmn Btmn y-on-y q-on-q Sales and service income 26,652 32,874 23.3% 9,691 10,866 11,751 21.3

impact to 2019 result as EGAT commits to make up energy consumption in 2H’2019)] and 2) Baht 125 million from one-time item (the impact on NNP to owner in Q2’2018 from realized FX gain from BIP debt

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30 September 2017 2018 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1

–2021 Balance by Quarter Change Q2–21 Q1–21 Q2–20 Q2–21 VS Q1–21 Q2–21 VS Q2–20 (Million Baht: MB) (MB) % (MB) % Total revenue 2,081.2 1,824.2 1,187.6 257.0 14.1 893.6 75.2 Total operating expenses